Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models

Published:2022-09-05 Issue:1 Volume:50 Page:168-183
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Li Cuicui,Liu Jun,Yang Xu,Yang Qi,Huang Wenpeng,Zhang Mingyu,Zhou Dandan,Wang Rong,Gong Jianhua,Miao Qingfang,Kang Lei,Yang Jigang^ORCID

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Beijing Science Foundation for Distinguished Young Scholars

Peking University Medicine Fund of Fostering Young Scholars’ Scientific & Technological Innovation

Clinical Medicine Plus X- Youth Scholars Project of Peking University

CAMS Innovation Fund for Medical Sciences

Natural Science Foundation of Shandong Province

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-022-05954-y.pdf

Reference36 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA A Cancer J Clin. 2021;71:7–33. https://doi.org/10.3322/caac.21654.

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

3. Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22:9694–705. https://doi.org/10.3748/wjg.v22.i44.9694.

4. Oberstein PE, Olive KP. Pancreatic cancer: why is it so hard to treat? Therap Adv Gastroenterol. 2013;6:321–37. https://doi.org/10.1177/1756283X13478680.

5. Wu M, Shu J. Multimodal molecular imaging: current status and future directions. Contrast Media Mol Imaging. 2018;2018:1382183. https://doi.org/10.1155/2018/1382183.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview;Journal of Nuclear Medicine;2024-05

2. A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers;npj Precision Oncology;2024-04-23

3. An electrochemical biosensor to assay Trop-2 of breast cancer cells fabricated by methylene blue-assisted assembly of DNA nanoparticles;Biosensors and Bioelectronics;2024-02

4. Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model;EJNMMI Radiopharmacy and Chemistry;2024-01-09

5. Trop2-targeted therapies in solid tumors: advances and future directions;Theranostics;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3